Parisa Farzanehfar1,2,3, Holly Woodrow4,5, Malcolm Horne4,5,6. 1. The Florey Institute of Neuroscience and Mental Health, Parkville, Australia. parisa.farzanehfar@florey.edu.au. 2. Northern Hospital, Epping, Australia. parisa.farzanehfar@florey.edu.au. 3. The University of Melbourne, Melbourne, Australia. parisa.farzanehfar@florey.edu.au. 4. The Florey Institute of Neuroscience and Mental Health, Parkville, Australia. 5. The University of Melbourne, Melbourne, Australia. 6. St Vincent's Hospital, Fitzroy, Australia.
Abstract
BACKGROUND: Development of "Wearing Off" (WO) of motor and non-motor function in Parkinson's disease (PD) adversely affects quality of life. This suggest that identifying and treating WO is important. However, identification of WO depends on people with PD (PwP) recognising and reporting WO and there is a perception that WO may be significantly underestimated. OBJECTIVE: We investigate the feasibility of identifying "Wearing Off" using objective measurement and assess the clinical benefit in rectifying it. METHOD: In this study, 200 PwP were studied for evidence of WO using a continuously worn wearable system. Eighty-five patients (43%) were found to have WO and treatment was changed to mitigate the effects of WO. RESULTS: Factors, such as duration of disease, high baseline MDS-UPDRS (motor component), high Percent Time in Bradykinesia (PTB), high Levodopa Equivalent Daily Dose (LEDD), frequent Levodopa doses and younger age of onset, are associated with severity of motor complications. Patients with more severe WO experienced worse motor and non-motor symptoms and lower quality of life. Quality of life significantly improved in PwP when WO was treated. CONCLUSION: The findings reported in this study provide evidence that identifying and treating WO improves outcomes of PwP and that objective measurements may help clinicians to identify and treat WO.
BACKGROUND: Development of "Wearing Off" (WO) of motor and non-motor function in Parkinson's disease (PD) adversely affects quality of life. This suggest that identifying and treating WO is important. However, identification of WO depends on people with PD (PwP) recognising and reporting WO and there is a perception that WO may be significantly underestimated. OBJECTIVE: We investigate the feasibility of identifying "Wearing Off" using objective measurement and assess the clinical benefit in rectifying it. METHOD: In this study, 200 PwP were studied for evidence of WO using a continuously worn wearable system. Eighty-five patients (43%) were found to have WO and treatment was changed to mitigate the effects of WO. RESULTS: Factors, such as duration of disease, high baseline MDS-UPDRS (motor component), high Percent Time in Bradykinesia (PTB), high Levodopa Equivalent Daily Dose (LEDD), frequent Levodopa doses and younger age of onset, are associated with severity of motor complications. Patients with more severe WO experienced worse motor and non-motor symptoms and lower quality of life. Quality of life significantly improved in PwP when WO was treated. CONCLUSION: The findings reported in this study provide evidence that identifying and treating WO improves outcomes of PwP and that objective measurements may help clinicians to identify and treat WO.
Entities:
Keywords:
Disease; Motor complications; Objective measurements; Parkinson’s; Wearable sensors; Wearing off
Authors: Angelo Antonini; Pablo Martinez-Martin; Ray K Chaudhuri; Marcelo Merello; Robert Hauser; Regina Katzenschlager; Per Odin; Mark Stacy; Fabrizio Stocchi; Werner Poewe; Oliver Rascol; Cristina Sampaio; Anette Schrag; Glenn T Stebbins; Christopher G Goetz Journal: Mov Disord Date: 2011-07-20 Impact factor: 10.338
Authors: Joohyung Lee; Wen-Mei Zhu; Davor Stanic; David I Finkelstein; Marjorie H Horne; Jasmine Henderson; Andrew J Lawrence; Louise O'Connor; Doris Tomas; John Drago; Malcolm K Horne Journal: Brain Date: 2008-05-16 Impact factor: 13.501
Authors: Rachel Rose; Emma Mitchell; Piet Van Der Graaf; Daisuke Takaichi; Jun Hosogi; Hugo Geerts Journal: J Pharmacokinet Pharmacodyn Date: 2022-10-09 Impact factor: 2.410
Authors: Jeroen G V Habets; Christian Herff; Pieter L Kubben; Mark L Kuijf; Yasin Temel; Luc J W Evers; Bastiaan R Bloem; Philip A Starr; Ro'ee Gilron; Simon Little Journal: Sensors (Basel) Date: 2021-11-26 Impact factor: 3.576
Authors: Sneha Mantri; Madeline Lepore; Briana Edison; Margaret Daeschler; Catherine M Kopil; Connie Marras; Lana M Chahine Journal: J Patient Cent Res Rev Date: 2021-07-19